13G Filing: Barrett Ehrlich and Oncbiomune Pharmaceuticals, Inc (OBMP)

Page 2 of 6 SEC Filing

CUSIP No. 68235A101   13G/A   Page 2 of 6 Pages
     
1.   NAMES
OF REPORTING PERSONS

I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(ENTITIES ONLY)


THE BARRETT EDGE INC. (46-2504958)
   
2.   CHECK THE
APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)
(a)    
(b)    
   
3.   SEC USE ONLY
 
   
4.   CITIZENSHIP OR PLACE
OF ORGANIZATION
 
NEW YORK
   
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
  5.   SOLE VOTING POWER
 
5,097,843
  6.   SHARED VOTING POWER
 
-0-
  7.   SOLE DISPOSITIVE POWER
 
5,097,843
  8.   SHARED DISPOSITIVE POWER
 
-0-
9.   AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON

*5,097,843
   
10.   CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(see instructions)    
   
11.   PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9)


9.9%
   
12.   TYPE OF REPORTING PERSON
(see instructions)


CO
   
  

FOOTNOTES

* Rebecca Guttman-Ehrlich and reporting
person Barrett Ehrlich have equal ownership in The Barrett Edge, Inc. and are the sole owners.

Follow Theralink Technologies Inc. (OTCMKTS:THER)